COVID-19 is driving patients to seek telehealth solutions, and it won’t be a short-term boom.
During an outbreak, it is critical to treat reusable medical devices as potential sources of transmission.
Expanded designs that enable clinicians to leverage data in making healthcare decisions, but privacy challenges remain.
Personalized medicine is the future of healthcare, and artificial intelligence will play a big role.
All of the issues that ECRI calls out on its list are preventable, so device manufacturers and healthcare providers should take serious note.
Device manufacturers must do more to integrate supplier and clinical perspectives during the product design process.
Few things motivate FDA faster than a significant number of adverse events, especially deaths.